Skip to main content
SpringerLink
Log in

Fatty Liver Disease in Children—What Should One Do?

  • Symposium on Chronic Noncommunicable Diseases and Children
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The world’s population is increasingly overweight and obese. According to the World Health Organization (WHO) as of 2010, 43 million children under the age of five were overweight. Once considered to be limited to developed countries, overweight and obese children are now found in low- and middle-income countries, though most commonly in urban areas. Furthermore the WHO now cites the conditions of overweight and obesity as being associated with more deaths around the globe than those associated with being underweight. With this increased prevalence of overweight and obese children has come a host of other medical problems including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This review will focus on NAFLD and NASH, their definitions, epidemiology, diagnosis and treatment. The authors will also discuss NAFLD in the Indian subcontinent, and the future of NAFLD and NASH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–8.

    PubMed  CAS  Google Scholar 

  2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.

    Article  PubMed  CAS  Google Scholar 

  3. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–93.

    Article  PubMed  Google Scholar 

  4. http://www.who.int/mediacentre/factsheets/fs311/en/index.html.

  5. de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92:1257–64.

    Article  PubMed  Google Scholar 

  6. Das K, Mukherjee PS, Ghosh A, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51:1593–602.

    Article  PubMed  CAS  Google Scholar 

  7. Kohli R, Boyd T, Lake K, et al. Rapid progression of NASH in childhood. J Pediatr Gastroenterol Nutr. 2010;50:453–6.

    PubMed  Google Scholar 

  8. Takuma Y, Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol. 2010;16:1436–41.

    Article  PubMed  CAS  Google Scholar 

  9. Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73.

    Article  PubMed  CAS  Google Scholar 

  10. Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6:161–3.

    PubMed  Google Scholar 

  11. Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A. 2006;103:18273–7.

    Article  PubMed  CAS  Google Scholar 

  12. Duseja A, Chawla Y. Nonalcoholic fatty liver disease in India—how much? How soon? Trop Gastroenterol. 2005;26:1–3.

    PubMed  Google Scholar 

  13. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:137–44.

    Article  PubMed  CAS  Google Scholar 

  14. Manco M, Bedogni G, Marcellini M, et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut. 2008;57:1283–7.

    Article  PubMed  CAS  Google Scholar 

  15. Messiah SE, Arheart KL, Lipshultz SE, Miller TL. Ethnic group differences in waist circumference percentiles among U.S. children and adolescents: estimates from the 1999–2008 national health and nutrition examination surveys. Metab Syndr Relat Disord. 2011;9:297–303.

    Article  PubMed  Google Scholar 

  16. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145:439–44.

    Article  PubMed  Google Scholar 

  17. Patton HM, Yates K, Unalp-Arida A, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol. 2010;105:2093–102.

    Article  PubMed  Google Scholar 

  18. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31.

    Article  PubMed  Google Scholar 

  19. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 y Gut. 2009;58:1538–44.

    Article  PubMed  CAS  Google Scholar 

  20. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008;118:277–83.

    Article  PubMed  CAS  Google Scholar 

  21. Lavine JE, Schwimmer JB, Van Natta ML, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305:1659–68.

    Article  PubMed  CAS  Google Scholar 

  22. Potter C, Hogan MJ, Henry-Kendjorsky K, Balint J, Barnard JA. Safety of pediatric percutaneous liver biopsy performed by interventional radiologists. J Pediatr Gastroenterol Nutr. 2011;53:202–6.

    Article  PubMed  Google Scholar 

  23. Pozzato C, Verduci E, Scaglioni S, et al. Liver fat change in obese children after a 1-y nutrition–behavior intervention. J Pediatr Gastroenterol Nutr. 2010;51:331–5.

    PubMed  CAS  Google Scholar 

  24. Engelmann G, Gebhardt C, Wenning D, et al. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012;171:353–60.

    Article  PubMed  Google Scholar 

  25. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008;135:32–40.

    Article  PubMed  Google Scholar 

  26. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259:749–56.

    Article  PubMed  Google Scholar 

  27. Alkhouri N, Carter-Kent C, Lopez R, et al. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol. 2011;9:150–5.

    Article  PubMed  Google Scholar 

  28. Kohli R, Kirby M, Xanthakos SA, et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 2010;52:934–44.

    Article  PubMed  CAS  Google Scholar 

  29. Banasch M, Ellrichmann M, Tannapfel A, Schmidt WE, Goetze O. The Non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. Eur J Med Res. 2011;16:258–64.

    Article  PubMed  CAS  Google Scholar 

  30. Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52:79–104.

    Article  PubMed  CAS  Google Scholar 

  31. Koot BG, van der Baan-Slootweg OH, Tamminga-Smeulders CL, et al. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Arch Dis Child. 2011;96:669–74.

    Article  PubMed  Google Scholar 

  32. Nobili V, Manco M, Ciampalini P, et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-m, observational pilot study. Clin Ther. 2008;30:1168–76.

    Article  PubMed  CAS  Google Scholar 

  33. Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;1:CD007340.

    PubMed  Google Scholar 

  34. Kohli R, Feldstein AE. NASH animal models: are we there yet? J Hepatol. 2011 May 8.

  35. Ibrahim SH, Kohli R, Gores GJ. Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr. 2011;53:131–40.

    Article  PubMed  CAS  Google Scholar 

  36. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology. 2010;52:894–903.

    Article  PubMed  CAS  Google Scholar 

  37. Yajnik CS. The insulin resistance epidemic in India: fetal origins, later lifestyle, or both? Nutr Rev. 2001;59:1–9.

    Article  PubMed  CAS  Google Scholar 

  38. Esparza-Romero J, Valencia ME, Martinez ME, Ravussin E, Schulz LO, Bennett PH. Differences in insulin resistance in Mexican and U.S. Pima Indians with normal glucose tolerance. J Clin Endocrinol Metab. 2010;95:E358–62.

    Article  PubMed  Google Scholar 

  39. Baig U, Belsare P, Watve M, Jog M. Can thrifty gene(s) or predictive fetal programming for thriftiness lead to obesity? J Obes. 2011;2011:861049.

    PubMed  Google Scholar 

Download references

Conflict of Interest

None.

Role of Funding Source

NIH 3K08DK084310 (Salary support to RK); NIH 5T32DK007727 (Salary support to KSB); NIH 5K23DK080888 (salary support to SAX).

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 45229, USA

    Kristin S. Bramlage, Stavra A. Xanthakos & Rohit Kohli

  2. Department of Medicine, Woodlands Hospital, National Health Group, Woodlands New Town, Singapore

    Vivek Bansal

Authors
  1. Kristin S. Bramlage
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivek Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stavra A. Xanthakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rohit Kohli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rohit Kohli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bramlage, K.S., Bansal, V., Xanthakos, S.A. et al. Fatty Liver Disease in Children—What Should One Do?. Indian J Pediatr 80 (Suppl 1), 109–114 (2013). https://doi.org/10.1007/s12098-012-0826-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-012-0826-5

Keywords

Search

Navigation